Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,743 | -17,382 | -4,324 | -25,653 | -21,206 |
| Depreciation Amortization | 81 | 53 | 26 | 5,731 | 5,704 |
| Accounts payable and accrued liabilities | -140 | -301 | -440 | 123 | -21 |
| Other Working Capital | -1,509 | -983 | -290 | 726 | 1,242 |
| Other Operating Activity | 9,524 | 9,145 | 272 | 2,136 | 2,035 |
| Operating Cash Flow | $-13,787 | $-9,468 | $-4,756 | $-16,937 | $-12,246 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -16 | N/A | -1 | -1 |
| Investing Cash Flow | $-35 | $-16 | $N/A | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,492 | 1,458 | 1,401 | N/A | N/A |
| Debt Repayment | -69 | -67 | -56 | -67 | -67 |
| Common Stock Issued | 6,973 | 6,694 | N/A | 5,563 | 5,556 |
| Other Financing Activity | 1,339 | 1,798 | 1,727 | 0 | 0 |
| Financing Cash Flow | $9,735 | $9,883 | $3,072 | $5,496 | $5,489 |
| Exchange Rate Effect | -44 | 62 | 93 | -132 | -9 |
| Beginning Cash Position | 11,705 | 11,705 | 11,705 | 23,279 | 23,279 |
| End Cash Position | 7,574 | 12,166 | 10,114 | 11,705 | 16,512 |
| Net Cash Flow | $-4,131 | $461 | $-1,591 | $-11,574 | $-6,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,787 | -9,468 | -4,756 | -16,937 | -12,246 |
| Capital Expenditure | -35 | -16 | N/A | -1 | -1 |
| Free Cash Flow | -13,822 | -9,484 | -4,756 | -16,938 | -12,247 |